Related Experiment Video
Updated: Sep 28, 2025
Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media
Published on: February 12, 2019
Comparative computational RNA analysis of cardiac-derived progenitor cells and their extracellular vesicles
Jessica R Hoffman1, Hyun-Ji Park2, Sruti Bheri2
1Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology & Emory University School of Medicine, Atlanta, GA, USA; Molecular & Systems Pharmacology Graduate Training Program, Graduate Division of Biological & Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA 30322, USA.
Abstract:
Stem/progenitor cells, including cardiac-derived c-kit+ progenitor cells (CPCs), are under clinical evaluation for treatment of cardiac disease. Therapeutic efficacy of cardiac cell therapy can be attributed to paracrine signaling and the release of extracellular vesicles (EVs) carrying diverse cargo molecules. Despite some successes and demonstrated safety, large variation in cell populations and preclinical/clinical outcomes remains a problem. Here, we investigated this variability by sequencing coding and non-coding RNAs of CPCs and CPC-EVs from 30 congenital heart disease patients and used machine learning methods to determine potential mechanistic insights. CPCs retained RNAs related to extracellular matrix organization and exported RNAs related to various signaling pathways to CPC-EVs. CPC-EVs are enriched in miRNA clusters related to cell proliferation and angiogenesis. With network analyses, we identified differences in non-coding RNAs which give insight into age-dependent functionality of CPCs. By taking a quantitative computational approach, we aimed to uncover sources of CPC cell therapy variability.
Insights
Cardiac progenitor cell therapy shows promise but has variable outcomes. This study used RNA sequencing and machine learning to identify molecular differences in cells and extracellular vesicles from patients, revealing insights into therapy variability.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Genomics
Background:
- Stem/progenitor cells, like cardiac-derived c-kit+ progenitor cells (CPCs), are being evaluated for cardiac disease treatment.
- Therapeutic success in cardiac cell therapy relies on paracrine signaling and extracellular vesicles (EVs), but outcomes vary significantly.
- Understanding the sources of this variability is crucial for optimizing CPC therapy.
Purpose of the Study:
- To investigate the sources of variability in cardiac progenitor cell (CPC) therapy.
- To analyze the coding and non-coding RNA content of CPCs and their EVs.
- To apply machine learning to uncover mechanistic insights into CPC functionality and therapeutic potential.
Main Methods:
- RNA sequencing of CPCs and CPC-derived EVs from 30 congenital heart disease patients.
- Machine learning and network analyses to identify patterns and differences in RNA expression.
- Comparative analysis of RNA cargo within CPCs versus exported to EVs.
Main Results:
- CPCs retained RNAs involved in extracellular matrix organization.
- CPCs exported RNAs linked to various signaling pathways to their EVs.
- CPC-derived EVs showed enrichment in miRNA clusters associated with cell proliferation and angiogenesis.
- Network analyses revealed age-dependent differences in non-coding RNA profiles, impacting CPC functionality.
Conclusions:
- Quantitative computational analysis of RNA profiles in CPCs and EVs can uncover sources of therapeutic variability.
- Understanding RNA cargo differences provides mechanistic insights into CPC function and potential age-related effects.
- This approach aids in optimizing CPC therapy for cardiac conditions by addressing inherent variability.
